John Skoko

John Skoko

Auto-generated profile, based on publicly available information

John Skoko

University of Pittsburgh, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
NWNobunao Wakabayashi
Nobunao Wakabayashi
SSStephen L. Slocum
Stephen L. Slocum
JSJohn J. Skoko
John J. Skoko
SSSoona Shin
Soona Shin
TKThomas W. Kensler
Thomas W. Kensler
Activation of the KEAP1-NRF2 signaling pathway is an adaptive response to environmental and endogenous stresses and serves to render animals resistant to chemical carcinogenesis and other forms of toxicity, whereas disruption of the pathway exacerbates these outcomes. This pathway, which can be activated by sulfhydryl-reactive, small-molecule pharmacologic agents, regulates the inducible expression of an extended battery of cytoprotective genes, often by direct binding of the transcription factor to antioxidant response elements in the promoter regions of target genes. However, it is becoming evident that some of the protective effects may be mediated indirectly through cross talk with additional pathways affecting cell survival and other aspects of cell fate. These interactions provide a multi-tiered, integrated response to chemical stresses. This review highlights recent observations on the molecular interactions and their functional consequences between NRF2 and the arylhydrocarbon receptor (AhR), NF-κB, p53, and Notch1 signaling pathways. Antioxid. Redox Signal. 13, 1649–1663.

1 April 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RKRada Koldamova
Rada Koldamova
ILIliya Lefterov
Iliya Lefterov
MIMilos D. Ikonomovic
Milos D. Ikonomovic
JSJohn Skoko
John Skoko
PLPreslav I. Lefterov
Preslav I. Lefterov
JLJohn S. Lazo
John S. Lazo
The ATP-binding cassette transporter A1 (ABCA1) is a major regulator of peripheral cholesterol efflux and plasma high density lipoprotein metabolism. In adult rat brain we found high expression of ABCA1 in neurons in the hypothalamus, thalamus, amygdala, cholinergic basal forebrain, and hippocampus. Large neurons of the cholinergic nucleus basalis together with CA1 and CA3 pyramidal neurons were among the most abundantly immunolabeled neurons. Glia cells were largely negative. Because cholesterol homeostasis may have an essential role in central nervous system function and neurodegeneration, we examined ABCA1 expression and function in different brain cell types using cultures of primary neurons, astrocytes, and microglia isolated from embryonic rat brain. The basal ABCA1 mRNA and protein levels detected in these cell types were increased markedly after exposure to oxysterols and 9-cis-retinoic acid, which are ligands for the nuclear hormone liver X receptors and retinoic X receptors, respectively. Functionally, the increased ABCA1 expression caused by these ligands was followed by elevated apoA-I- and apoE-specific cholesterol efflux in neurons and glia. In non-neuronal and neuronal cells overexpressing a human Swedish variant of amyloid precursor protein, 22R-hydroxycholesterol and 9-cis-retinoic acid induced ABCA1 expression and increased apoA-I-mediated cholesterol efflux consequently decreasing cellular cholesterol content. More importantly, we demonstrated that these ligands alone or in combination with apoA-I caused a substantial reduction in the stability of amyloid precursor protein C-terminal fragments and decreased amyloid beta production. These effects of 22R-hydroxycholesterol may provide a novel strategy to decrease amyloid beta secretion and consequently reduce the amyloid burden in the brain.

1 May 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AVAndreas Vogt
Andreas Vogt
ATAletheia Tamewitz
Aletheia Tamewitz
JSJohn Skoko
John Skoko
RSRachel P. Sikorski
Rachel P. Sikorski
KGKenneth A. Giuliano
Kenneth A. Giuliano
JLJohn S. Lazo
John S. Lazo
Mitogen-activated protein kinase phosphatase-1 (MKP-1) is a dual specificity phosphatase that is overexpressed in many human tumors and can protect cells from apoptosis caused by DNA-damaging agents or cellular stress. Small molecule inhibitors of MKP-1 have not been reported, in part because of the lack of structural guidance for inhibitor design and definitive assays for MKP-1 inhibition in intact cells. Herein we have exploited a high content chemical complementation assay to analyze a diverse collection of pure natural products for cellular MKP-1 inhibition. Using two-dimensional Kolmogorov-Smirnov statistics, we identified sanguinarine, a plant alkaloid with known antibiotic and antitumor activity but no primary cellular target, as a potent and selective inhibitor of MKP-1. Sanguinarine inhibited cellular MKP-1 with an IC50 of 10 microM and showed selectivity for MKP-1 over MKP-3. Sanguinarine also inhibited MKP-1 and the MKP-1 like phosphatase, MKP-L, in vitro with IC50 values of 17.3 and 12.5 microM, respectively, and showed 5-10-fold selectivity for MKP-3 and MKP-1 over VH-1-related phosphatase, Cdc25B2, or protein-tyrosine phosphatase 1B. In a human tumor cell line with high MKP-1 levels, sanguinarine caused enhanced ERK and JNK/SAPK phosphorylation. A close congener of sanguinarine, chelerythrine, also inhibited MKP-1 in vitro and in whole cells, and activated ERK and JNK/SAPK. In contrast, sanguinarine analogs lacking the benzophenanthridine scaffold did not inhibit MKP-1 in vitro or in cells nor did they cause ERK or JNK/SAPK phosphorylation. These data illustrate the utility of a chemical complementation assay linked with multiparameter high content cellular screening.

1 February 2014 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
NWNobunao Wakabayashi
Nobunao Wakabayashi
JSJohn J. Skoko
John J. Skoko
DCDionysios V. Chartoumpekis
Dionysios V. Chartoumpekis
SKShoko Kimura
Shoko Kimura
SSStephen L. Slocum
Stephen L. Slocum
TKThomas W. Kensler
Thomas W. Kensler
The Notch signaling pathway enables regulation and control of development, differentiation, and homeostasis through cell-cell communication. Our investigation shows that Notch signaling directly activates the Nrf2 stress adaptive response pathway through recruitment of the Notch intracellular domain (NICD) transcriptosome to a conserved Rbpjκ site in the promoter of Nrf2. Stimulation of Notch signaling through Notch ligand expression in cells and by overexpression of the NICD in RosaNICD/−::AlbCre mice in vivo induces expression of Nrf2 and its target genes. Continuous and transient NICD expression in the liver produces a Notch-dependent cytoprotective response through direct transcriptional activation of Nrf2 signaling to rescue mice from acute acetaminophen toxicity. This response can be reversed upon genetic disruption of Nrf2. Morphological studies showed that the characteristic phenotype of high-density intrahepatic bile ducts and enlarged liver in RosaNICD/−::AlbCre mice could be at least partially reversed after Nrf2 disruption. Furthermore, the liver and bile duct phenotypes could be recapitulated with constitutive activation of Nrf2 signaling in Keap1F/F::AlbCre mice. It appears that Notch-to-Nrf2 signaling is another important determinant in liver development and function and promotes cell-cell cytoprotective signaling responses.

1 February 2016 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
SSStephen L. Slocum
Stephen L. Slocum
JSJohn J. Skoko
John J. Skoko
NWNobunao Wakabayashi
Nobunao Wakabayashi
SASusan Aja
Susan Aja
MYMasayuki Yamamoto
Masayuki Yamamoto
Dionysios ChartoumpekisDionysios Chartoumpekis
Dionysios Chartoumpekis

1 December 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Dushani L PalliyaguruDushani L Palliyaguru
Dushani L Palliyaguru
DCDionysios V. Chartoumpekis
Dionysios V. Chartoumpekis
NWNobunao Wakabayashi
Nobunao Wakabayashi
JSJohn J. Skoko
John J. Skoko
YYYoko Yagishita
Yoko Yagishita
TKThomas W. Kensler
Thomas W. Kensler